citalopram

1
Reactions 893 - 16 Mar 2002 Citalopram First report of photosensitivity: case report A 50-year-old woman experienced a photosensitivity reaction after she started receiving citalopram for depression. The woman started treatment with citalopram 20 mg/day with the dosage increased to 40 mg/day after 2 months. Eight months later, she presented with diffuse, brownish-black pigmentation of sun-exposed areas of her skin, which had started when her citalopram dosage was increased and had gradually progressed. A photoprovocation test on non-sun- exposed areas resulted in darkening of her skin. A punch biopsy revealed an atrophic epidermis, pigmentary incontinence with melanophages, and sun-damaged collagen all through the dermis. The woman stopped receiving citalopram and avoided sun exposure. Six months later, her photosensitivity reaction had partially regressed. Author comment: ‘We observed a diffuse photopigmentation after administration of citalopram (40 mg/day) without any inflammatory reaction indicating non- allergic response in our patient. Moreover, no known poor metabolizer of CYP2C19 could be identified.’ Inaloz HS, et al. Citalopram-induced photopigmentation. Journal of Dermatology 28: 742-745, Dec 2001 - Turkey 807208451 » Editorial comment: A search of AdisBase and Medline did not reveal any previous case reports of photosensitivity associated with citalopram. The WHO Adverse Drug Reactions database contains 32 reports of photosensitivity reactions associated with citalopram. 1 Reactions 16 Mar 2002 No. 893 0114-9954/10/0893-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: lexuyen

Post on 20-Mar-2017

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Citalopram

Reactions 893 - 16 Mar 2002

★Citalopram

First report of photosensitivity: case reportA 50-year-old woman experienced a photosensitivity

reaction after she started receiving citalopram for depression.The woman started treatment with citalopram 20 mg/day

with the dosage increased to 40 mg/day after 2 months. Eightmonths later, she presented with diffuse, brownish-blackpigmentation of sun-exposed areas of her skin, which hadstarted when her citalopram dosage was increased and hadgradually progressed. A photoprovocation test on non-sun-exposed areas resulted in darkening of her skin. A punchbiopsy revealed an atrophic epidermis, pigmentaryincontinence with melanophages, and sun-damaged collagenall through the dermis.

The woman stopped receiving citalopram and avoided sunexposure. Six months later, her photosensitivity reaction hadpartially regressed.

Author comment: ‘We observed a diffusephotopigmentation after administration of citalopram (40mg/day) without any inflammatory reaction indicating non-allergic response in our patient. Moreover, no known poormetabolizer of CYP2C19 could be identified.’Inaloz HS, et al. Citalopram-induced photopigmentation. Journal of Dermatology28: 742-745, Dec 2001 - Turkey 807208451

» Editorial comment: A search of AdisBase and Medline didnot reveal any previous case reports of photosensitivityassociated with citalopram. The WHO Adverse Drug Reactionsdatabase contains 32 reports of photosensitivity reactionsassociated with citalopram.

1

Reactions 16 Mar 2002 No. 8930114-9954/10/0893-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved